Mixtard 50 HM Penfil (Mixtard 50 HM Penfil)100IU/mL

Mixtard 50 HM Penfil (Mixtard 50 HM Penfil)100IU/mL

$57.00

Each Mixtard 50 contins 100 iu / ml Insulin NPH and Insulin Regular. It is used to lower blood sugar in patients with high blood sugar (diabetes).

ATC Classification: A10AD
Active Ingrediant: Insulin NPH and Insulin Regular
Generic Name: Mixtard 50 HM Penfil
Manufacturer: Novo Nordisk Brazil
Strength: 100IU/ml
Dosage Type: Cartridge
Packaging Type: Box
Contains: 5X 3 ML Cartridge

Description

Insulin NPH and Insulin Regular Information

Pronunciation

IN soo lin N P H & IN soo lin REG yoo ler

What is this drug used for?

• It is used to lower blood sugar in patients with high blood sugar (diabetes).

Frequently reported side effects of this drug

• Injection site irritation

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Low blood sugar like dizziness, headache, fatigue, feeling weak, shaking, fast heartbeat, confusion, increased hunger, or sweating.

• Low potassium like muscle pain or weakness, muscle cramps, or an abnormal heartbeat.

• Anxiety

• Vision changes

• Chills

• Severe dizziness

• Passing out

• Mood changes

• Seizures

• Slurred speech

• Shortness of breath

• Excessive weight gain

• Swelling of arms or legs

• Injection site thick skin, pits, or lumps

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

Medication Safety Issues

Sound-alike/look-alike issues:

HumuLIN 70/30 may be confused with HumaLOG Mix 75/25, HumuLIN R, NovoLIN 70/30, NovoLOG Mix 70/30

NovoLIN 70/30 may be confused with HumaLOG Mix 75/25, HumuLIN 70/30, HumuLIN R, NovoLIN R, and NovoLOG Mix 70/30

High alert medication:

The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error. Due to the number of insulin preparations, it is essential to identify/clarify the type of insulin to be used.

Other safety concerns:

Cross-contamination may occur if insulin pens are shared among multiple patients. Steps should be taken to prohibit sharing of insulin pens.

Product Availability

Novolin 70/30 FlexPen: FDA approved June 2018; anticipated availability is currently unknown.

Storage and Stability

Humulin 70/30:

Vials: Store unopened vials in refrigerator between 2°C and 8°C (36°F to 46°F) or at room temperature below 30°C (86°F). If stored at room temperature, the vial must be discarded after 31 days. Do not freeze; discard if frozen. Keep away from heat and sunlight. Once punctured (in use), vials may be stored for up to 31 days in the refrigerator between 2°C and 8°C (36°F to 46°F) or at room temperature ≤30°C (≤86°F).

KwikPen: Store unopened pen in a refrigerator between 2°C and 8°C (36°F to 46°F) or at room temperature below 30°C (86°F); if stored at room temperature, then unopened pen must be discarded after 10 days. Do not freeze; discard if frozen. Keep away from heat and sunlight. Once punctured (in use), pen should be stored at room temperature below 30°C (86°F) for up to 10 days; do not refrigerate in-use pens.

Novolin 70/30:

Vials: Store unopened vials in refrigerator between 2°C and 8°C (36°F to 46°F) until product expiration date or at room temperature ≤25°C (≤77°F) for up to 42 days. Do not freeze; discard if frozen. Keep away from heat and sunlight. Once punctured (in use), store vials at room temperature ≤25°C (≤77°F) for up to 42 days; do not refrigerate in-use vials.

FlexPen: Store unopened pens in refrigerator between 2°C and 8°C (36°F to 46°F) until product expiration date or at room temperature <30°C (≤86°F) for up to 28 days. Do not freeze; discard if frozen. Keep away from heat and sunlight. Once in use, store pens at room temperature ≤30°C (≤86°F) for up to 28 days; do not refrigerate in-use pens.

Canadian products: All products: Unopened vials, cartridges, and pens should be stored under refrigeration between 2°C and 8°C (36°F to 46°F) until the expiration date. Do not freeze; discard if frozen. Keep away from heat and sunlight. Once punctured (in use), Humulin vials, cartridges, and pens should be stored at room temperature <25°C (<77°F) for up to 4 weeks. Once punctured (in use), Novolin ge vials, cartridges, and pens may be stored for up to 1 month at room temperature <25°C (<77°F) for vials or <30°C (<86°F) for pens/cartridges; do not refrigerate.

Adverse Reactions

See individual agents. Frequency not defined.

Cardiovascular: Peripheral edema

Dermatologic: Pruritus

Endocrine & metabolic: Hypoglycemia, hypokalemia, weight gain

Hypersensitivity: Hypersensitivity reaction

Immunologic: Immunogenicity

Local: Hypertrophy at injection site, lipoatrophy at injection site

Brand

Novo Nordisk

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Reviews

There are no reviews yet.

Be the first to review “Mixtard 50 HM Penfil (Mixtard 50 HM Penfil)100IU/mL”

Your email address will not be published.